Latest Cystic Fibrosis Foundation Stories
VERONA, Italy, January 15, 2015 /PRNewswire/ -- CROMSOURCE, an international provider of outsourced services to the pharmaceutical, biotechnology and medical device industries,
Global Cystic Fibrosis Market 2015-2019 is a new industry research report which profiles key players like Actavis, Novartis, Gilead Sciences, Vertex Pharmaceuticals and F Hoffmann-La Roche.
BOULDER, Colo., Dec. 22, 2014 /PRNewswire/ -- N30 Pharmaceuticals, Inc.
BOULDER, Colo., Nov. 19, 2014 /PRNewswire/ -- N30 Pharmaceuticals, Inc.
Funds will be used to expand cystic fibrosis research, care and patient programs BETHESDA, Md., Nov.
Largest pharmaceutical royalty purchase ever completed NEW YORK, Nov.
NIH Awards Two Grants to Academic Partners to Progress Mucolytic Research Program DURHAM, N.C., Oct.
SAN DIEGO, Oct.
Collaborative Forum to Focus on Promising Advances in Drug Development, Research and Care for People with CF ATLANTA, Oct.
ChanTest’s expertise will be showcased at the North American Cystic Fibrosis Conference this month, highlighting the important research the company has conducted to help move cystic fibrosis
- The act of burning, scorching, or heating to dryness; the state or being thus heated or dried.
- In medicine, cauterization.